VIRX

Viracta Therapeutics, Inc. Common Stock

Delisted

VIRX was delisted on the 3rd of February, 2025.

62 hedge funds and large institutions have $151M invested in Viracta Therapeutics, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 11 increasing their positions, 12 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

8% less call options, than puts

Call options by funds: $885K | Put options by funds: $961K

8% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 12

Holders
62
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$885K
Puts
$961K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
26
$495K
27
$421K
28
$407K
29
$377K
30
$352K
31
$341K
32
$317K
33
$248K
34
$244K
35
$192K
36
$167K
37
$164K
38
$163K
39
$158K
40
$128K
41
$117K
42
$114K
43
$95K
44
$81K
45
$42K
46
$35K
47
$32K
48
$23K
49
$19K
50
$8.49K